                         SEQUENCE LISTING

<110>  THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE 
       SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
       RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK ON 
       BEHALF OF BROOKLYN COLLEGE
 
<120>  CHEMICAL ENTITIES FOR LYTIC ACTIVATION OF KSHV AND THERAPEUTIC 
       TARGETING OF VIRAL ENZYMES/PROTEINS

<130>  4239-99726-02

<150>  US 62/598,807
<151>  2017-12-14

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  27
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  1
atgtatttag gattggaact tcttgag                                           27


<210>  2
<211>  28
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  2
ctcaagaagt tccaatccta aatacata                                          28


